1 2 European drug report 2014: Trends and developments (PDF) (Report)
Researchers must dissolve the compounds via a slow, gentle swirling motion, avoiding any aggressive mechanical agitation, inversion, or shaking
First generation: short-acting Exenatide (Byetta) was the first GLP-1 receptor agonist approved by the FDA in 2005
Cold chain done right
Nous avons des activits diversifies dans la R&D, production, ventes et aussi la ngociation
Interestingly, according to the weight loss and increased IGF-2 levels, patients treated with liraglutide showed changes in adipose tissue distribution with reduction of the visceral adipose tissue, which expresses IGF-2, IGF-2 receptors and IR